Brandicourt Olivier

Executive

US·SEC (Form 4)

BeiGene, Ltd.Alnylam Pharmaceuticals, Inc.BeOne Medicines Ltd.Vaxcyte, Inc.

Total declarations

Companies

▲ Purchases (1 ops.)

—

▼ Sales (0 ops.)

—

Latest filing published 16 Jun 2026 for Vaxcyte, Inc.. Read the official filing

Insider track record

Disclosed buys

Disclosed sells

T+90 hit rate

50%

T+90 mean return

+21.6%

Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.

Signal history

Brandicourt Olivier: trading record in brief

This profile gathers the share dealings of Brandicourt Olivier across 3 companies, led by BeOne Medicines Ltd., Vaxcyte, Inc. and Alnylam Pharmaceuticals, Inc. Between 5 June 2024 and 15 June 2026, the trades on record add up to 9 filings.

On the market, this insider has only ever bought: 1 purchase. The amount is not disclosed for 1 filing. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 8 share grants. 2026 to date brings 1 purchase and no sales.

The newest entry dates from 16 June 2026: a share grant, in Vaxcyte, Inc. The latest purchase dates back some time: it was published 124 days ago, on 16 June 2026. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.